Where can I find HEPA's financial statements?

Hepion Pharmaceuticals, Inc. (HEPA)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for HEPA?

Hepion Pharmaceuticals, Inc. (HEPA) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does HEPA update its statements?

Hepion Pharmaceuticals, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

HEPA

Hepion Pharmaceuticals, Inc.

OTC·Biotechnology · Healthcare

$0.07$0.01−12.16%

After hours·$0.07+0.00%

Market cap$756.84K·Market closed·Aug 26 8:00 PM UTC

USD · values shown as reported

Line item	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Gross profit	$0.00	$0.00	$0.00	$0.00	$0.00
Research & development	$20.40M+70.0%	$33.27M+63.1%	$35.64M+7.1%	$11.85M−66.8%	$445.51K−96.2%
General & administrative	$10.01M+22.8%	$10.35M+3.4%	$9.62M−7.1%	$7.50M−22.0%	$3.32M−55.8%
SG&A (combined)	$10.01M+22.8%	$10.35M+3.4%	$9.62M−7.1%	$7.50M−22.0%	$3.32M−55.8%
Other operating expenses	—	$1.87M	$3.19M+70.5%	—	$402.75K
Total operating expenses	$30.40M+50.9%	$45.49M+49.6%	$48.45M+6.5%	$19.35M−60.1%	$4.16M−78.5%
Operating income	−$30.40M−50.9%	−$45.49M−49.6%	−$48.45M−6.5%	−$19.35M+60.1%	−$4.16M+78.5%
Interest expense	$8.86K−71.6%	$10.16K+14.7%	$9.47K−6.9%	$1.25M+13,078.2%	$24.41K−98.0%
Other income / (expense), net	−$2.32M−1,208.0%	$404.83K+117.5%	−$887.11K−319.1%	$3.18M+459.0%	−$4.11M−229.2%
Income before tax	−$32.72M−61.0%	−$45.08M−37.8%	−$49.34M−9.4%	−$16.16M+67.2%	−$8.28M+48.8%
Income tax expense	—	−$2.88M	−$409.02K+85.8%	−$2.97M−625.9%	—
Net income	−$32.72M−60.8%	−$42.20M−29.0%	−$48.93M−15.9%	−$13.19M+73.0%	−$8.28M+37.3%

EPS (basic)	−$465.52+77.9%	−$594.75−27.8%	−$616.07−3.6%	−$107.35+82.6%	−$0.88+99.2%
EPS (diluted)	−$465.52+77.9%	−$594.75−27.8%	−$616.07−3.6%	−$107.35+82.6%	−$0.88+99.2%
Weighted avg shares (basic)	70,291	76,229	79,416	122,894	9,409,375
Weighted avg shares (diluted)	70,291	76,229	79,416	122,894	9,409,375

Depreciation & amortization	$86.07K+149.4%	$77.46K−10.0%	$67.13K−13.3%	$30.76K−54.2%	$30.76K+0.0%
EBITDA	−$32.63M−62.2%	−$45.00M−37.9%	−$49.26M−9.5%	−$14.88M+69.8%	−$3.73M+74.9%

Frequently Asked Questions About HEPA

Where can I find HEPA's financial statements?: Hepion Pharmaceuticals, Inc. (HEPA)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for HEPA?: Hepion Pharmaceuticals, Inc. (HEPA) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does HEPA update its statements?: Hepion Pharmaceuticals, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.